Stockscreener 앱 받기
17.59
0.23%
-0.04
시간 외 거래:
17.96
0.37
+2.10%
전일 마감가:
$17.63
열려 있는:
$17.74
하루 거래량:
5.76M
Relative Volume:
0.59
시가총액:
$9.08B
수익:
$11.24B
순이익/손실:
$-900.00M
주가수익비율:
-10.48
EPS:
-1.679
순현금흐름:
$323.00M
1주 성능:
+5.84%
1개월 성능:
+1.09%
6개월 성능:
-22.92%
1년 성능:
-38.02%
1일 변동 폭
$17.57
$18.05
1주일 범위
$16.81
$18.05
52주 변동 폭
$15.73
$32.68
박스터 인터내셔널 Stock (BAX) Company Profile
명칭
Baxter International Inc
전화
(224) 948-2000
주소
ONE BAXTER PARKWAY, DEERFIELD, IL
Compare BAX vs ISRG, BDX, ALC, MDLN, RMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BAX
Baxter International Inc
|
17.59 | 8.85B | 11.24B | -900.00M | 323.00M | -1.679 |
ISRG
Intuitive Surgical Inc
|
467.22 | 160.05B | 10.06B | 2.88B | 2.49B | 7.876 |
BDX
Becton Dickinson Co
|
155.73 | 43.87B | 21.92B | 1.76B | 2.63B | 6.1223 |
ALC
Alcon Inc
|
79.94 | 38.02B | 10.40B | 980.00M | 1.61B | 1.9749 |
MDLN
Medline Inc
|
47.67 | 37.01B | 28.43B | 1.16B | 1.26B | 1.4457 |
RMD
Resmed Inc
|
230.69 | 33.34B | 5.40B | 1.49B | 1.78B | 10.12 |
박스터 인터내셔널 Stock (BAX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-31 | 다운그레이드 | Argus | Buy → Hold |
| 2025-08-04 | 다운그레이드 | Stifel | Buy → Hold |
| 2025-08-01 | 다운그레이드 | Goldman | Buy → Neutral |
| 2025-02-26 | 재개 | Goldman | Buy |
| 2025-02-24 | 업그레이드 | Argus | Hold → Buy |
| 2025-02-20 | 재개 | Barclays | Overweight |
| 2024-07-15 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2024-05-30 | 개시 | Goldman | Neutral |
| 2024-05-10 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2023-05-30 | 재개 | Morgan Stanley | Equal-Weight |
| 2023-03-29 | 개시 | UBS | Neutral |
| 2023-01-06 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2023-01-05 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2023-01-03 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-12-19 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-12-15 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2022-12-12 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-10-18 | 개시 | Barclays | Overweight |
| 2022-10-12 | 개시 | Jefferies | Hold |
| 2022-06-24 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2022-04-04 | 다운그레이드 | Goldman | Neutral → Sell |
| 2022-03-02 | 재개 | BofA Securities | Buy |
| 2022-02-18 | 재확인 | KeyBanc Capital Markets | Overweight |
| 2022-02-18 | 재확인 | Morgan Stanley | Overweight |
| 2022-02-18 | 재확인 | Raymond James | Outperform |
| 2022-02-18 | 재확인 | Stifel | Buy |
| 2022-02-18 | 재확인 | UBS | Neutral |
| 2022-02-18 | 재확인 | Wells Fargo | Overweight |
| 2022-02-11 | 개시 | Goldman | Neutral |
| 2022-01-07 | 재개 | Citigroup | Buy |
| 2022-01-07 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2021-09-13 | 업그레이드 | Cowen | Market Perform → Outperform |
| 2021-09-03 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2021-05-25 | 개시 | Barclays | Equal Weight |
| 2021-01-29 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2021-01-06 | 다운그레이드 | UBS | Buy → Neutral |
| 2020-12-15 | 다운그레이드 | Goldman | Buy → Neutral |
| 2020-10-01 | 업그레이드 | Citigroup | Neutral → Buy |
| 2020-09-04 | 다운그레이드 | Argus | Buy → Hold |
| 2020-06-24 | 개시 | Oppenheimer | Outperform |
| 2020-03-19 | 업그레이드 | Stifel | Hold → Buy |
| 2020-03-18 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-03-05 | 개시 | Citigroup | Neutral |
| 2020-02-13 | 개시 | Goldman | Buy |
| 2020-01-02 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2019-12-17 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2019-06-26 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2019-04-08 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2019-01-02 | 업그레이드 | Citigroup | Neutral → Buy |
| 2019-01-02 | 업그레이드 | Morgan Stanley | Underweight → Overweight |
| 2018-11-02 | 업그레이드 | Argus | Hold → Buy |
| 2018-10-16 | 개시 | Barclays | Underweight |
| 2018-05-17 | 재개 | Piper Jaffray | Overweight |
| 2018-02-06 | 재확인 | Citigroup | Neutral |
| 2018-01-03 | 개시 | Evercore ISI | Outperform |
| 2018-01-03 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
모두보기
박스터 인터내셔널 주식(BAX)의 최신 뉴스
Baxter Showcases Recent Innovations at AORN Global Surgical Conference and Expo 2026 - marketscreener.com
Baxter Showcases Recent Innovations at AORN Global Surgical Conference & Expo 2026 - National Today
Baxter Highlights New Surgical and Patient Support Products - National Today
Baxter International Inc. stock outperforms competitors on strong trading day - MarketWatch
Baxter Showcases Recent Innovations at AORN Global Surgical Conference & Expo 2026 (1) - PharmiWeb.com
BAX Showcases Innovative Products at Global Surgical Conference - GuruFocus
Gap Down: Is Baxter International Inc a cyclical or defensive stockQuarterly Growth Report & Growth Focused Investment Plans - baoquankhu1.vn
Short Squeeze: Is Baxter International Inc a cyclical or defensive stock2026 Macro Moves & Low Risk Growth Stock Ideas - baoquankhu1.vn
Baxter Launches Pilot Program for Therapy Animals in Healthcare Settings - respiratory-therapy.com
Baxter International Provides FY 2026 Earnings Guidance - National Today
Baxter (NYSE: BAX) exec holds 31K shares plus 25.9K options - Stock Titan
Baxter (NYSE: BAX) surgery chief lists common shares and option grants - Stock Titan
[Form 3] BAXTER INTERNATIONAL INC Initial Statement of Beneficial Ownership - Stock Titan
J&J Defends Blood-Clotting Powder IP From Baxter Attack - Law360
Robotic Pharmacy Prescription Market Research and Global Forecast Report 2025-2032 - GlobeNewswire Inc.
Baxter to Host First-Quarter 2026 Financial Results Conference Call for Investors - marketscreener.com
Baxter schedules April 30 webcast for first-quarter 2026 results - Stock Titan
Baxter International Inc (BAX) Stock Price, Trades & News - GuruFocus
Medical Syringe Market Is Booming So Rapidly Growth by 2033| - openPR.com
Hologic hires former Baxter International chief as next CEO - Radiology Business
Former Baxter chief takes helm at Marlborough medical device maker - The Business Journals
Baxter International Inc. (BAX) Stock Price, News, Quote & History - Yahoo! Finance Canada
Fund Update: 3,614,465 BAXTER INTERNATIONAL (BAX) shares added to GREENHAVEN ASSOCIATES INC portfolio - Quiver Quantitative
Evercore ISI Group Lowers Price Target for Baxter International (BAX) to $22 | BAX Stock News - GuruFocus
Baxter Introduces the IV Verify Line Labeling System, an Automated Solution to Improve IV Labeling in Healthcare Settings - Bioscience Association Manitoba
Evercore ISI Adjusts Baxter International Price Target to $22 From $23, Maintains Outperform Rating - marketscreener.com
Evercore Maintains Baxter International Inc(BAX.US) With Buy Rating, Cuts Target Price to $22 - 富途牛牛
Assessing Baxter (BAX) Valuation After Launch Of IV Verify Line Labeling System - simplywall.st
Aug PreEarnings: Can Baxter International Inc deliver alphaEarnings Miss & Reliable Price Breakout Signals - baoquankhu1.vn
Does Baxter’s New IV Verify Labeling System Redefine Its Automation Edge In Healthcare Workflow Efficiency (BAX)? - Sahm
How Investors May Respond To Baxter International (BAX) Expanding Into Automated IV Line Labeling Systems - Yahoo Finance
BAXTER INTERNATIONAL INC. R (BTL.HM) Q2 FY2025 earnings call transcript - Yahoo Finance
Baxter International unveils IV Verify to enhance IV labeling accuracy - msn.com
List of 21 Acquisitions by Baxter (Apr 2026) - Tracxn
Columbia Intrinsic Value Fund's Baxter International Inc(BAX) Holding History - GuruFocus
Baxter’s IV Verify Launch Tests Medication Safety Strategy And Hospital Traction - simplywall.st
Baxter International Introduces IV Verify to Improve the Precision of IV Labeling - Bitget
Baxter International Unveils IV Verify to Enhance IV Labeling Accuracy - Yahoo Finance
Pet Partners, Baxter Foundation Expand Therapy Animal Programs for Patients, Healthcare Workers - Pet Age
Baxter (BAX) Unveils New IV Verify Line Labeling System for Nurs - GuruFocus
Baxter International Inc. stock outperforms competitors despite losses on the day - MarketWatch
Baxter International Hits New 52-Week Low at $15.87 - Markets Mojo
Baxter International Inc (BAX) Stock Price Down 4.2% on Mar 30 - GuruFocus
Baxter launches IV labeling system aimed at improving safety, efficiency - Medical Economics
Pet Partners and the Baxter Foundation Expand Therapy Animal Programs to Support 100,000 Patients and Healthcare Workers in Two-Year Pilot - Bioscience Association Manitoba
Baxter debuts automated IV line labeling system By Investing.com - in.investing.com
Baxter debuts automated IV line labeling system - Investing.com
Baxter Foundation Therapy Animal Push And What It Means For Investors - Sahm
Baxter stock price forecast: bearish trend persists as BAX trades near 52-week lows - Traders Union
Baxter International Inc. stock underperforms Friday when compared to competitors - MarketWatch
Baxter International (NYSE:BAX) Hits New 1-Year LowTime to Sell? - MarketBeat
박스터 인터내셔널 (BAX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.39%
0.13%
자본화:
|
볼륨(24시간):